Schizophrenia is a complex and debilitating psychiatric disorder characterized by disturbances in thinking, perception, emotions and behavior. Pharmacotherapy remains a cornerstone in the management of schizophrenia, aimed at alleviating symptoms and improving quality of life. This article explores the global trends in neuropsychopharmacological prescriptions for adults with schizophrenia, examining the evolving landscape of medication choices, usage patterns and emerging therapies.
HTML PDFShare this article
Pharmacoeconomics: Open Access received 95 citations as per Google Scholar report
